ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Vermont » Internal Medicine

Top Internal Medicine Prescribers in Vermont

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
TEIG MARCO M.D.

Internal Medicine

13,856

$803K

452
382 are 65+

17%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $63

MARK STICKNEY M.D.

Internal Medicine

13,392

$715K

543
485 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $63

MARK HAMILTON M.D.

Internal Medicine

12,507

$574K

737
551 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $63

ROBERT TREMBLEY MD

Internal Medicine

12,237

$829K

360
284 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $63

PETER STICKNEY MD

Internal Medicine

11,924

$864K

428
368 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $63

EUGENE MOORE MD

Internal Medicine

10,677

$696K

381
316 are 65+

14%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $63

CHRISTOPHER RICKMAN MD

Internal Medicine

10,564

$921K

321
248 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$87
Average prescription price

Avg: $63

MARK PITCHER M.D.

Internal Medicine

9,192

$584K

450
381 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $63

CHRISTOPHER HEBERT MD

Internal Medicine

9,145

$566K

394
344 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $63

THOMAS ZIOBROWSKI MD

Internal Medicine

8,995

$477K

419
339 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $63

ROBERT ROBINSON M.D.

Internal Medicine

8,780

$552K

320
238 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $63

MARK LOGAN MD

Internal Medicine

8,620

$528K

350
249 are 65+

14%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $63

ERIC SEYFERTH M.D.

Internal Medicine

8,480

$557K

258
238 are 65+

4%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$66
Average prescription price

Avg: $63

ROGER KELLOGG M.D.

Internal Medicine

8,473

$503K

348
303 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

14%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $63

PETER DALE MD

Internal Medicine

8,327

$412K

359
304 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $63

MICHAEL CORRIGAN MD

Internal Medicine

8,260

$635K

330
186 are 65+

22%
patients receiving schedule two controlled substances

Avg: 10%

18%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$77
Average prescription price

Avg: $63

ROBERT ZELAZO MD

Internal Medicine

8,243

$601K

311
229 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $63

SUSAN ERISMAN M.D.

Internal Medicine

8,117

$484K

377
284 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $63

PETER HARRIS MD

Internal Medicine

7,867

$448K

289
211 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $63

MARK YORRA M.D.

Internal Medicine

7,834

$405K

278
233 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $63

JOHN DICK MD

Internal Medicine

7,711

$423K

352
275 are 65+

6%
patients receiving schedule two controlled substances

Avg: 10%

3%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $63

ROBERT PRIMEAU MD

Internal Medicine

7,673

$473K

316
226 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $63

SETH COOMBS MD

Internal Medicine

7,451

$459K

369
317 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $63

MILTON FOWLER M.D.

Internal Medicine

7,287

$351K

358
319 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $63

BRADFORD ARMSTRONG MD

Internal Medicine

7,180

$415K

354
309 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $63

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank